Alpha Centric Advisors LLC Pacira Bio Sciences, Inc. Transaction History

Alpha Centric Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $381,640 - $497,495	14,500 Added 14.08%	117,500 $3.96 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $1.43 Million - $1.86 Million	46,500 Added 82.3%	103,000 $3.16 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $47.5 $740,460 - $973,750	20,500 Added 56.94%	56,500 $2.26 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $604,010 - $737,460	17,000 Added 89.47%	36,000 $1.47 Million
Q4 2022 Feb 07, 2023	BUY	$38.19 - $57.45 $725,610 - $1.09 Million	19,000 New	19,000 $734,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.